de
en
Reading time: approx. 7 to 9 minutes.
Switzerland follows its own legal approach to cannabis. High THC cannabis products remain generally prohibited, while hemp and CBD products below 1% THC are classified differently and scientific pilot programs test regulated access models.
This guide explains the key rules on the THC threshold, possession of small amounts, CBD products, hemp, cannabis seeds and pilot programs. It contains no consumption recommendation, no cultivation instruction and no individual legal advice.
Status: June 2026. Current Swiss legal texts and official authority information remain decisive.
Brief classification
Switzerland is not a full legalization model. The key points are the 1% THC threshold, the special position of hemp and CBD products, the treatment of small quantities for personal use and the scientifically limited pilot trials.
Legal status in Switzerland: no free cannabis market
In Switzerland, cannabis with a THC content of at least 1% is generally prohibited. At the same time, Swiss law clearly distinguishes between high THC cannabis products and products below that threshold.
This creates a legal market for certain hemp and CBD products, while high THC flowers, resin, extracts or other cannabis products may still fall under narcotics law. This separation is the core of the Swiss model.
Important: Switzerland does not simply allow cannabis in general. Product form, THC content, purpose and regulatory category remain decisive.
The 1% THC threshold as the central distinction
The 1% THC threshold is especially important for legal classification in Switzerland. Cannabis products below this threshold are treated differently from products that reach or exceed it.
Basic Swiss classification model
| Area | Classification | Note |
|---|---|---|
| 1% THC or more | generally prohibited | High THC cannabis products fall under narcotics law. |
| below 1% THC | not treated as a prohibited cannabis drug | Further product rules may still apply depending on category. |
| Pilot trials | limited exception | Only within officially approved scientific programs. |
The threshold alone does not answer every legal question. For CBD products, food law, cosmetics law, tobacco law, medicines law, labelling and advertising may also be relevant.
Possession of small amounts and consumption
Possession of up to 10 g of cannabis for personal use is not considered a criminal offence in Switzerland. This does not create general legalization. Cannabis use itself can still be punished with an administrative fixed penalty.
For a clean classification, possession, consumption, transfer, sale, import and cultivation must be separated. Sale, commercial handling and high THC products remain much more legally sensitive than the small quantity question alone.
No consumption advice: This guide explains the legal framework. It does not provide advice on places of use, consumption behaviour or avoiding sanctions.
CBD products, hemp and cannabis seeds
CBD products and hemp products with less than 1% THC are generally possible in Switzerland if the relevant product rules are met. The concrete classification depends heavily on whether the product is a flower, oil, cosmetic, food, tobacco substitute, chemical product or another category.
Medical claims or health related promises are especially sensitive. A low THC value does not automatically mean that every product can be marketed, sold or used without restrictions.
For hemp seed, the purpose, product context and later plant material must be separated from high THC cannabis flowers or plants. Seeds may be assessed differently from THC rich cannabis products, but they should not be used as a shortcut to unlawful production.
Important dividing lines
- CBD product: check THC value and product category.
- Hemp below 1% THC: not automatically free from all product obligations.
- Cannabis seeds: purpose, origin and later use should be considered.
- High THC products: remain legally sensitive.
Pilot programs in Swiss cities
Switzerland is testing scientifically supervised pilot trials with regulated access to cannabis in several cities and municipalities. These programs are based on a specific legal basis and are limited in time, place and organization.
Participants receive access only within the respective study and under clearly defined rules. The pilot programs research regulation, public health protection, consumption behaviour, counselling and market structures.
Importantly, pilot trials are not general cannabis legalization. They do not create free distribution outside approved studies and do not replace a general legal framework.
Background: Study on cannabis market regulation in Switzerland
Switzerland compared with Germany and Austria
Switzerland differs clearly from the German model. Germany uses regulated partial legalization with possession limits, private home cultivation and cultivation associations. Austria remains more restrictive and has no German-style three plant rule.
Countries at a glance
| Country | Model | Short description |
|---|---|---|
| Switzerland | pilot model with 1% THC threshold | High THC products remain generally prohibited, CBD and hemp below 1% THC are classified separately. |
| Germany | regulated partial legalization | Possession, home cultivation and cultivation associations under strict statutory limits. |
| Austria | restrictive model | No general legalization and no German-style three plant rule. |
FAQ about cannabis in Switzerland
Quick answer: High THC cannabis is generally prohibited. Products below 1% THC are treated differently.
Switzerland does not have a free legalization model. Pilot trials are scientifically limited special models.
Quick answer: Possession of up to 10 g for personal use is not considered a criminal offence.
This does not mean general legality. Consumption and other actions can still have legal consequences.
Quick answer: Products below 1% THC may be allowed if the relevant product rules are met.
Depending on product type, food law, cosmetics law, tobacco law, chemicals law or medicines law may also apply.
Quick answer: No. Pilot trials are limited scientific models.
They allow regulated access only within approved studies and do not create a free market.
Conclusion: Switzerland clearly separates THC, CBD and pilot models
Switzerland remains on its own path in 2026. High THC cannabis products are generally prohibited, while hemp and CBD products below 1% THC are treated separately and pilot trials scientifically examine regulated models.
For legal classification, THC content, product form, purpose, possession, consumption, cultivation and possible pilot authorizations are decisive. A single word such as “legal” or “decriminalized” is not enough for Switzerland.
Official basis:
Federal Office of Public Health: Cannabis legal situation
Federal Office of Public Health: Cannabis pilot trials
Swiss Narcotics Act, Fedlex
Federal Office for Agriculture: Hemp